INTRODUCTION
============

The use of gastrostomy has expanded over the past decade, and new techniques have been developed that have made the procedure simpler and less risky [@b1-cln_71p169]. Gastrostomy is specifically a technique that allows direct access to the stomach to provide food to disabled patients for several reasons. Most commonly, this condition occurs in patients with neurological diseases, impairment following a stroke or obstructive head and neck tumors [@b1-cln_71p169],[@b2-cln_71p169].

The absence of systematic reviews and meta-analyses directly comparing endoscopic gastrostomy and surgical gastrostomy (SG) techniques for all pathologies, whether benign or malignant, in the literature was one of the main reasons for conducting the present comparative review of surgical and endoscopic methods for all pathologies that may result in gastrostomy, taking into account major and minor complications. Two related reviews were found in the literature, but both of these considered specific pathologies. The first, carried out by Grant et al. [@b9-cln_71p169], investigated gastrostomy complications in patients with head and neck tumors and compared radiological methods with endoscopy, not considering the surgical method. The other, by Burkitt et al. [@b2-cln_71p169], similarly compared complications in patients with head and neck tumors but did not address other pathologies and only compared radiological techniques with endoscopy, given that endoscopic gastrostomy has become the technique of choice for carrying out the procedure, with SG only used in cases where the endoscopic procedure is not viable. Most studies associate SG with higher rates of complications and mortality [@b4-cln_71p169],[@b7-cln_71p169].

Several techniques for gastrostomy tube insertion have been described. These techniques include percutaneous endoscopic gastrostomy (PEG) and SG (open SG (OSG) or surgical laparoscopic gastrostomy (SLG)) [@b2-cln_71p169]. SG was initially suggested in 1837 by Egeberg, a Norwegian surgeon and the first successful gastrostomy was carried out nearly 40 years later, in 1876, by Verneuil in Paris, France [@b1-cln_71p169][@b2-cln_71p169][@b3-cln_71p169].

The SLG method also avoids the need for a laparotomy but still requires general anesthesia. Although not an absolute contraindication, prior upper abdominal surgery may make the SLG method difficult and risky [@b8-cln_71p169]. The SLG method additionally offers better exposure of the stomach than the open technique, in which the incision is usually quite small. However, PEG has nearly entirely displaced SG in clinical practice because the PEG procedure can be carried out more easily and without general anesthesia, which is beneficial for the usually elderly, high-risk patient population. In addition, PEG avoids the mortality and morbidity associated with laparotomy. Despite the minor invasiveness of endoscopic placement of percutaneous feeding tubes, complications remain an important problem [@b2-cln_71p169],[@b3-cln_71p169].

There is widespread acceptance of PEG as the insertion technique of choice owing to its simplicity and effectiveness, but certain patients are not candidates for an endoscopic approach [@b10-cln_71p169]. The present review provides greater evidence in the current context as to which of these procedures is associated with major complications and mortality.

METHODS
=======

Protocol and registration
-------------------------

The present review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) recommendations [@b7-cln_71p169] and it has been registered in the PROSPERO international database ([www.crd.york.ac.uk/prospero/](www.crd.york.ac.uk/prospero/)) under number CRD42015016493 [@b20-cln_71p169].

Eligibility criteria
--------------------

1.  Types of studies: randomized controlled trials and retrospective studies.

2.  Type of participant: patients undergoing gastrostomy.

3.  Types of interventions: PEG (intervention) and SG (comparison).

4.  Types of outcome measures: the main outcome parameters were minor and major complications and mortality directly related to the procedure.

There is no literature on the exact classification of complications related to gastrostomy and authors have classified these complications in various ways. The methods used here are those found most often in published studies. Complications may be secondary to endoscopic procedures or directly related to gastrostomy, such as cardiopulmonary complications, hypoxemia, phlebitis, bacteremia, perforation and bleeding. Minor complications are treated conservatively. Major complications may require hospitalization [@b9-cln_71p169],[@b2-cln_71p169],[@b22-cln_71p169], blood transfusions, or endoscopic or surgical therapy. The period in which complications occur may be early (until 15 days) or late (after 15 days) [@b10-cln_71p169]. For the present review, both major and minor complications were considered, whether early or late [@b2-cln_71p169],[@b12-cln_71p169],[@b22-cln_71p169].

**Major complications.** Bowel perforation, Gastrointestinal hemorrhage, Gastrocutaneous fistula, Intra-abdominal abscess, Peristomal abscess, Peritonitis requiring surgery, Loss of catheter tract, Aspiration pneumonia, Sepsis, Buried bumper syndrome, Early inadvertent removal of tube.

**Minor complications.** Dislodged tubes, Inadvertent removal of tubes, Tube malfunction, Other tube problems conservatively managed, Peristomal leaks, Peristomal infection, Mild skin necrosis, Wound granulation, Minor wound bleeding, Wound hematoma, Post-procedure ileus, Symptomatic pneumoperitoneum, Subcutaneous emphysema, Regurgitation, Unsuccessful procedure.

Information sources
-------------------

The electronic databases searched were MEDLINE (via PubMed), Embase, Scopus, LILACS, the Cochrane Library (via BVS), and CINAHL (via EBSCO), from inception until February 2015.

Search
------

The descriptors used for the study were as follows: ((Gastrostomies OR Gastrostomie OR Gastrostomy OR Percutaneous endoscopic gastrostomy)) AND random\*.

Study selection
---------------

The process of including or excluding studies according to PRISMA is presented as a flow chart. The eligibility assessment and selection of records shown were performed independently in a standardized manner by two reviewers. Disagreements between the reviewers were resolved by consensus and the search was conducted in all languages, with no limit regarding time.

Studies comparing patients undergoing endoscopic gastrostomy and SG were included regardless of cause and enrolled patients aged over 18 years and with a minimum period of one month of follow-up. Abstracts, letters, editorials, expert opinions, case reports and reviews were excluded. Studies that did not consider the desired outcomes or that compared other techniques were also not included.

Data collection process and items
---------------------------------

Data were extracted independently by two reviewers (JGPB, BWM) using forms (checklists) that are standard for cohort studies [@b8-cln_71p169] and randomized clinical trials [@b7-cln_71p169]. The data were drawn from all studies comparing endoscopic gastrostomy and SG using the following as main variables: endoscopic gastrostomy, gastrostomy, follow-up, early and late complications and minor and major complications. Complications not related to the procedure, mortality not related to the procedure, were excluded.

Risk of bias
------------

Publication bias was assessed by two independent reviewers and retrospective and randomized studies were evaluated separately. For retrospective studies, the Newcastle scale [@b18-cln_71p169] was used based on the Jadad score for cohort studies and randomized studies [@b11-cln_71p169]. The strength of evidence was evaluated using the Oxford Centre\'s recommendations for evidence-based medicine [@b19-cln_71p169]. The results of the evaluation were shown to be valid and reliable. Potential confounding factors were identified, as many authors do not take these important aspects into account in their analyses, which can lead to bias. The primary outcome measures used had also to be clearly indicated in the study. If they were not indicated or if the study based its findings on key secondary endpoints, the study was rejected.

Planned methods of analysis
---------------------------

The analysis was performed using Review Manager (RevMan) 5.3 [@b21-cln_71p169] from the Cochrane Informatics & Knowledge Management Department website. Risk differences for dichotomous variables were computed using a fixed-effects model and the respective forest and funnel plots were obtained. Data on risk differences and the 95% confidence intervals (CIs) for each outcome were calculated using the Mantel-Haenszel test. Inconsistency (heterogeneity) was qualified and reported using the Chi-squared (Chi^2^) and Higgins methods and was termed I^2^. Data on the absolute risk reduction (ARR) or increase (ARI) and the number needed to treat (NNT) or harm (NNH) were obtained for validity and applicability using Critically Appraised Topics (CAT) software [@b19-cln_71p169].

RESULTS
=======

Initially, 2,042 studies were retrieved. A total of 2,024 studies were excluded for various reasons after reading: 720 presented no direct comparison of the techniques under study, 104 were narrative reviews and another 1,200 had no direct relation to the review. For evaluation and eligibility, the full text of the remaining eighteen articles was read and eleven studies were further excluded for various reasons: two studies compared endoscopic gastrostomy with gastrojejunostomy, six were comparative reviews of radiological and endoscopic techniques and three were case series. Selected a total of seven studies of the remaining studies, two were prospective randomized studies and five were retrospective cohort studies. The retrospective and randomized studies were evaluated independently. Few randomized studies compared one technique with the other. All strategies and the selection procedure are represented in the diagram below ([Figure 1](#f1-cln_71p169){ref-type="fig"}).

Study characteristics
---------------------

Seven studies were included for review, including two randomized controlled trials and five retrospective cohort studies. The total population was 406 individuals, with 232 having undergone endoscopic gastrostomy and 172 having undergone SG. The main indications were neurological; traumatic; tumors of the head and neck; and other situations, such as stenosis or esophageal atresia ([Table 1](#t1-cln_71p169){ref-type="table"}). All studies used the Gauderer-Ponsky or "pull" endoscopic gastrostomy technique described in 1980 [@b17-cln_71p169],[@b24-cln_71p169],[@b27-cln_71p169]. Certain studies did not mention whether the patients received antibiotic prophylaxis. The main outcomes studied were procedure-related complications, divided into major, minor and mortality complications directly related to the procedure.

Risk of bias within studies
---------------------------

For the prospective randomized studies, the Jadad score [@b11-cln_71p169], ranging from 0 to 5, was used and only the studies with a Jadad score ≥3 were selected. For observational studies, the Newcastle-Ottawa rating scale [@b12-cln_71p169] was used and only studies with a score ≥6, of a maximum total of 9 points, were selected. Publication bias is related to what is likely to be published among what is available to be published (Tables 4 and 5, Supplementary file).

Results of individual studies
-----------------------------

Of the 406 patients in total, 232 had undergone PEG and 174 had undergone SG. Among these patients, 27 major complications were observed, 16 of which were related to the endoscopic procedure and 11 of which were related to the surgical procedure. Minor complications occurred in 57 patients with SG and in 56 with PEG. Moreover, mortality related to the procedures was higher in the group with SG (five cases) compared with the group with PEG (one case).

All complications in retrospective studies
------------------------------------------

In the retrospective studies, with a sample of 205 individuals, complications occurred in 125 for PEG and in 77 for SG [@b23-cln_71p169],[@b4-cln_71p169],[@b6-cln_71p169],[@b16-cln_71p169],[@b29-cln_71p169]. There was no significant difference favoring either group.

Major complications in retrospective studies
--------------------------------------------

Of a total of 18 complications, 12 were for PEG and 6 were for SG. There was no significant difference between the four studies. Only one study [@b29-cln_71p169] showed a significant difference (95% CI (0.333 to 0.547), ARR=10.7%, NNT=9, i.e., it would be necessary to treat nine patients for one to have a higher number of complications) ([Table 2](#t2-cln_71p169){ref-type="table"}). Analysis of the retrospective studies [@b23-cln_71p169],[@b4-cln_71p169],[@b6-cln_71p169],[@b16-cln_71p169],[@b29-cln_71p169] showed that the most frequent major complications were peritonitis requiring surgical intervention, aspiration and sepsis, with certain cases resulting in death.

Minor complications in retrospective studies
--------------------------------------------

Of 59 minor complications reported in the retrospective studies, 31 were for PEG and 28 were for SG; this difference was not significant ([Table 2](#t2-cln_71p169){ref-type="table"}). The most frequent complications were small tube leaks, stoma leakage, displacement of the tube and superficial cellulitis. There was no death related to minor complications in most studies ([Table 2](#t2-cln_71p169){ref-type="table"}) [@b23-cln_71p169],[@b4-cln_71p169],[@b6-cln_71p169],[@b16-cln_71p169],[@b29-cln_71p169].

Mortality related to the procedure in retrospective studies
-----------------------------------------------------------

Three deaths related to the procedure occurred, all of which were following SG. The leading causes of death were peritonitis and aspiration pneumonia. The risk difference analysis did not show a statistically significant trend favoring any group. Mortality occurred in only three retrospective studies ([Table 2](#t2-cln_71p169){ref-type="table"}) [@b23-cln_71p169],[@b6-cln_71p169],[@b16-cln_71p169].

All complications in randomized studies
---------------------------------------

Among the 201 patients in total, there were 104 complications for PEG and 97 for SG. In all, 29 complications were related to PEG and 42 were related to SG. There was no significant difference between the groups ([Table 3](#t3-cln_71p169){ref-type="table"}).

Major complications in randomized studies
-----------------------------------------

Four complications occurred in the PEG group and 5 occurred in the SG group. There was no significant difference between PEG and SG. The most common major complications were pneumonia and peritonitis ([Table 3](#t3-cln_71p169){ref-type="table"}).

Minor complications in randomized studies
-----------------------------------------

Of 52 complications, 25 were related to PEG and 27 were related to SG. The study by Ljungdahl et al. [@b14-cln_71p169] showed that PEG was associated with significantly fewer minor complications compared with SG (95% CI (0.124 to 0.562), ARR = 0.343, NNT=3, i.e., it would be necessary to treat three patients for minor complications). The most common complications were leaks around the tube, wound infection, dislodged tubes, and stoma leakage ([Table 3](#t3-cln_71p169){ref-type="table"}).

Procedure-related mortality in randomized studies
-------------------------------------------------

Three deaths were related to the procedures, with one in the PEG group and two related to SG in the study by Ljungdahl et al. [@b14-cln_71p169]. In contrast, in the study by Stiegmann et al. [@b26-cln_71p169], there were no deaths related to the procedure. The main cause of death was aspiration pneumonia. However, there was no significant difference between PEG and SG ([Table 3](#t3-cln_71p169){ref-type="table"}).

Summary of results (meta-analyses) Risk of bias across studies and additional analyses
--------------------------------------------------------------------------------------

### Risk of bias across studies and additional analyses

The data on effect estimates and CIs for each study are illustrated graphically below. The numerical group-specific summary information, effect sizes, CIs and percentage weights are also presented in the following tables. Sensitivity analysis was carried out using the heterogeneity test and is represented in the form of forest and funnel plots.

There was no statistically significant difference between PEG and SG (risk difference = -0.04, 95% CI (-0.18 to 0.10), [Figure 2a](#f2-cln_71p169){ref-type="fig"}). For major and minor complications in particular, there was no difference between PEG and SG (risk difference = -0.00, 95% CI (-0.11 to 0.10)), [Figure 2b](#f2-cln_71p169){ref-type="fig"} and risk difference = -0.04, 95% CI (-0.17 to 0.09), [Figure 2c](#f2-cln_71p169){ref-type="fig"}, respectively). Additionally, for mortality related to the procedures ([Figure 8](#f8-cln_71p169){ref-type="fig"}), there was no difference between PEG and SG (risk difference = -0.06, 95% CI (-0.15 to 0.03), [Figure 2d](#f2-cln_71p169){ref-type="fig"}). Sensitivity analysis for retrospective studies ([Figure 4](#f4-cln_71p169){ref-type="fig"}[Figure 5](#f5-cln_71p169){ref-type="fig"}[Figure 6](#f6-cln_71p169){ref-type="fig"}[Figure 7](#f7-cln_71p169){ref-type="fig"}).

In the randomized studies related to endoscopic gastrostomy, the procedure was associated with significantly fewer complications (risk difference = -0.15, 95% CI (-0.27 to -0.03)), although high heterogeneity (I^2^=89%) was present ([Figure 3a](#f3-cln_71p169){ref-type="fig"}1-a2). The study by Ljungdahl [@b3-cln_71p169] was outside of the funnel, which could indicate important bias in the interpretation ([Figure 8a](#f8-cln_71p169){ref-type="fig"}, Supplementary file) that PEG is associated with fewer complications. Furthermore, its weight in the analysis was 34% lower compared with the value in the study by Stiegmann [@b14-cln_71p169] or at 65.1%, which led to a new analysis of sensitivity and exclusion of the study by Ljungdahl [@b3-cln_71p169] ([Figure 8b](#f8-cln_71p169){ref-type="fig"}, Supplementary file). No significant difference was found (risk difference = -0.01, 95% CI (-0.22 to 0.20)) between PEG and SG ([Figure 3a](#f3-cln_71p169){ref-type="fig"}1-a2).

Regarding major complications in the randomized studies, the forest plot demonstrated no significant difference between PEG and SG (risk difference = -0.01, 95% CI (-0.07 to 0.05), [Figure 3b](#f3-cln_71p169){ref-type="fig"}). In sensitivity analysis funnel plot of major complications in randomized studies. All studies are inside the funnel plot (Figure 9). Regarding minor complications in the randomized studies, the forest plot showed that PEG was associated with significantly fewer complications compared with SG (risk difference = -0.13, 95% CI (-0.25 to -0.02)). There was great heterogeneity between studies, which may have been due to the varying characteristics of the studies, times of publication and distributions of the populations as well as other population differences ([Figure 3c](#f3-cln_71p169){ref-type="fig"}). In the analysis of sensitivity, two studies were found to lie inside the funnel plot, demonstrating true heterogeneity ([Figure 10](#f10-cln_71p169){ref-type="fig"}, Supplementary file). Regarding mortality related to the procedures in the randomized studies, there was no significant difference between PEG and SG (risk difference = -0.01, 95% CI (-0.05 to 0.03), [Figure 3d](#f3-cln_71p169){ref-type="fig"}).

DISCUSSION
----------

The aim of the present systematic review and meta-analysis was to compare the complications and mortality directly related to PEG and SG. Seven studies were included, namely, two prospective randomized studies and five retrospective studies and these were evaluated differently, given that there are few published randomized studies comparing the two techniques. The review demonstrates, via separate analyses of the randomized trials, that endoscopic gastrostomy has a low rate of minor complications compared with SG. In contrast, the retrospective studies exhibited no significant differences.

Endoscopic gastrostomy is used as the method of choice in nearly all centers worldwide, replacing SG [@b24-cln_71p169],[@b25-cln_71p169],[@b30-cln_71p169]. Many studies indicate that SG is associated with more complications and higher mortality, mainly because it is a more invasive procedure with a longer recovery period. In addition, this method is more expensive and involves operating room reservations and an anesthesia team in 100% of cases and in certain cases, patients need intensive care. Although more practical, SG is also associated with complications and mortality. In particular, several studies have reported many complications and considerable cases of mortality linked to this procedure and there have additionally been many unreported cases of complications and mortality directly associated with the procedure [@b12-cln_71p169],[@b13-cln_71p169]. Many of these complications and cases of mortality involve seriously ill patients, the bedridden, or the elderly, with multiple comorbidities during hospitalization.

Despite high heterogeneity in the randomized studies [@b14-cln_71p169],[@b26-cln_71p169], in the sensitivity analysis, it was found that there was true heterogeneity and inconsistency (outliers outside of the funnel). There were no significant differences between the two techniques regarding major complications or mortality related to the procedure in either the retrospective or randomized studies. Analysis of overall complications in the randomized trials revealed that SG had a higher rate of complications, but when sensitivity was analyzed and discrepancies (outliers) were removed, there was no difference between the two techniques.

Another problem is the lack of adequate standardization in the literature regarding the definitions of major and minor complications, which has also been a key factor in increasing bias. Both SG and endoscopic gastrostomy are associated with many complications, large and small. Specifically, there are many reports of complications that led to the death of patients as a result of associated diseases. For example, Grant et al. [@b9-cln_71p169] assessed complications of PEG in patients with head and neck tumors; a total of 253 gastrostomy cases were observed, with 1% of deaths, 3.3% of minor complications and 28.9% of major complications related to PEG. Additionally, many studies do not report whether they used antibiotics for prophylaxis, which reduces complications and mortality from infections. In a study by Lipp et al. [@b1-cln_71p169], 1,100 patients in ten randomized clinical trials were evaluated and the use of antibiotic prophylaxis was found to reduce complications related to infections [@b1-cln_71p169]. In the present review and meta-analysis, the main major complications reported were pneumonia aspiration, sepsis, and peritonitis, and the main minor complications were wound infection, probe displacement, and leakage at the site of the puncture.

### Limitations

-   Few randomized studies are available in the literature

-   There is a lack of recent studies comparing the two techniques using the means available today

-   There is a lack of uniformity in surgical techniques in studies

-   Certain studies do not mention whether they used antibiotic prophylaxis or not

-   Many retrospective studies have a small population

-   There is a lack of standardization regarding major and minor complications

This review indicates that PEG and SG are equivalent methods based on the evidence and that, furthermore, PEG is associated with fewer comorbidities.

Separate analysis of retrospective and randomized studies revealed no differences between the methods in relation to mortality and major complications, with low levels of minor complications for endoscopic procedures in randomized studies and no difference observed when compared with retrospective studies.
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###### 

Characteristics of retrospective and randomized studies.

  Authors                                                     Country   Population                                                                                                                       Comparison   Sample (n=523)   Method   Mean age (years)   Follow-up
  ----------------------------------------------------------- --------- -------------------------------------------------------------------------------------------------------------------------------- ------------ ---------------- -------- ------------------ -----------
  **Rustom et al. [@b23-cln_71p169]  2006 retrospective**     England   Head and neck tumors                                                                                                             PEG          40               Pull\*   63                 18 M
                                                                                                                                                                                                         SG           10               OSG\*    65                 
  **Cosentini et al. [@b4-cln_71p169]  1998 retrospective**   Austria   Oropharyngeal cancer, head and neck cancer, neurological disorder                                                                PEG          35               Pull     58                 17 M
                                                                                                                                                                                                         SG           4                OSG      28                 
  **Wollman et al. [@b30-cln_71p169] 1995 retrospective**     USA       Neurological impairment, head and neck cancer, gastrointestinal decompression                                                    PEG          69               Pull     61                 1 M
                                                                                                                                                                                                         SG           62               OSG      54                 
  **Muller et al. [@b16-cln_71p169]  1999 retrospective**     Sweden    Neurological disorder, malignant cancer, other                                                                                   PEG          24               Pull     55                 1 M
                                                                                                                                                                                                         SG           14               OSG      39                 
  **Edelman et al. [@b6-cln_71p169]  1994 retrospective**     USA       Inability to eat, malnutrition, recurrent aspiration, head and neck or esophageal tumor, esophageal obstruction from radiation   PEG          17               Pull     81                 1 M
                                                                                                                                                                                                         SG           14               SLG\*    61                 
  **Ljungdahl et al. [@b21-cln_71p169] 2006 randomized**      Sweden    Stroke, neurological disease, oropharyngeal cancer, cerebral trauma                                                              PEG          35               Pull     69                 45 M
                                                                                                                                                                                                         SG           35               OSG      65                 
  **Stiegmann et al. [@b21-cln_71p169]  1990 randomized**     USA       Oropharyngeal cancer, head and neck cancer, esophageal stricture                                                                 PEG          12               Pull     48                 4 M
                                                                                                                                                                                                         SG           35               OSG      71                 

OSG: open surgical gastrostomy; SG: surgical gastrostomy; PEG: percutaneous endoscopic gastrostomy; Pull: method of percutaneous gastrostomy; SLG: surgical laparoscopic gastrostomy.

###### 

Statistical summary of complications and mortality for retrospective studies.

                                    EVIDENCE SUMMARY                                         
  --------------------------------- ------------------ ------- ----------- ----------------- ----
  **All complications**                                                                      
  *Rustom et al. 2006*              12/40              8/10    0.100(R)    -0.256 to 0.398   NS
  *Cosentini et al. 1998*           16/24              5/14    0.071(R)    -0.245 to 0.445   NS
  *Wollman et al. 1995*             9/35               1/41    -0.007(I)   -0.455 to 0.441   NS
  *Moller et al. 1999*              2/12               1/35    -0.147(I)   -0.114 to 0.408   NS
  *Edelman et al. 1994*             4/17               1/14    0.227(R)    -0.78 to 0.46     NS
                                    128                77                                    
  **Major complications**                                                                    
  *Rustom et al. 2006*              0/40               1/10    0.100(R)    -0.086 to 0.134   NS
  *Cosentini et al. 1998*           4/24               2/14    -0.024(I)   -0.260 to 0.212   NS
  *Wollman et al. 1995*             5/35               1/4     0.107(R)    0.333 to 0.547    9
  *Moller et al. 1999*              1/12               1/35    -0.054(I)   -0.220 to 0.112   NS
  *Edelman et al. 1994*             2/17               1/14    -0.047(I)   -0.251 to 0.157   NS
                                    128                77                                    
  **Minor complications**                                                                    
  Rustom et al. 2006                16/40              4/10    0.000(R)    -0.339 to 0.339   NS
  Cosentini et al. 1998             8/24               6/14    0.096(R)    -0.225 to 0.417   NS
  Wollman et al. 1995               4/35               0/4     0.114(R)    -0.219 to 0.009   NS
  Moller et al. 1999                1/12               10/35   0.203(R)    -0.113 to 0.410   NS
  Edelman et al. 1994               2/17               0/14    0.164(R)    -0.406 to 0.078   NS
                                    128                77                                    
  **Procedure-related mortality**                                                            
  *Rustom et al. 2006*              0/40               1/10    0.100(R)    -0.086 to 0.286   NS
  *Cosentini et al. 1998*           0/24               0/14    0(R)        0                 NS
  *Wollman et al. 1995*             0/35               0/4     0(R)        0                 NS
  *Moller et al. 1999*              0/12               1/35    0.029(R)    -0.027 to 0.085   NS
  *Edelman et al. 1994*             0/17               1/14    0.071(R)    -0.064 to 0.206   NS
                                    128                77                                    

PEG: percutaneous endoscopic gastrostomy; SG: surgical gastrostomy; ARR/ARI: absolute risk reduction or increase -- (R): reduction, (I): increase; 95% CI: 95% confidence interval; NNT/NNH: number needed to treat or harm, (-): negative, NS: not statistically significant; Interv: intervention.

###### 

Statistical summary of complications and mortality for randomized studies.

                                    EVIDENCE SUMMARY                                          
  --------------------------------- ------------------ ------- ------------ ----------------- ----
  **All complications**                                                                       
  Ljungdahl et al. 2006             13/35              27/35   0.400(R)     -0.188 to 0.612   NS
  Stiegmann et al. 1990             16/69              15/62   -0.010(I)    -0.136 to 0.156   NS
                                    104                97                                     
  **Major complications**                                                                     
  Ljungdahl et al. 2006             0/35               2/35    -0.057(I)    -0.020 to 0.134   NS
  Stiegmann et al. 1990             4/69               3/62    -0.054(I)    -0.087 to 0.067   NS
                                    104                97                                     
  **Minor complications**                                                                     
  Ljungdahl et al. 2006             13/35              25/35   0.343(R)     0.124 to 0.562    3
  Stiegmann et al. 1990             12/69              12/62   0.020(R)     -0.133 to 0.153   NS
                                    104                97                                     
  **Procedure-related mortality**                                                             
  Ljungdahl et al. 2006             1/35               2/35    0\. 028(R)   -0.067 to 0.123   NS
  Stiegmann et al. 1990             0/69               0/62    0(R)         0                 NS
                                    104                97                                     

PEG: percutaneous endoscopic gastrostomy; SG: surgical gastrostomy; ARR/ARI: absolute risk reduction or increase -- (R): reduction, (I): increase; 95% CI: 95% confidence interval; NNT/NNH: number needed to treat or harm, (-): negative, NS: not statistically significant ; Interv: intervention.

[^1]: Bravo JG was responsible for the study design, data collection, data analysis, data interpretation, literature search, generation of figures, manuscript writing. Moura ET was responsible for the study design, data collection, data analysis, data interpretation, literature search. Kondo A, Moura DT were responsible for the study design and manuscript writing. Ide E, Sakai P were responsible for the study design and manuscript writing. Bernardo WM was responsible for the study design, data collection, data analysis, data interpretation, literature search. Moura EG was responsible for the study design, data collection, data analysis, data interpretation, literature search, generation of figures, manuscript writing.
